These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 33682961

  • 21. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer.
    Zhou C, Chen Z, Zhao L, Zhao W, Zhu Y, Liu J, Zhao X.
    J Clin Lab Anal; 2020 Nov; 34(11):e23505. PubMed ID: 33463758
    [Abstract] [Full Text] [Related]

  • 22. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
    Giallombardo M, Chacártegui Borrás J, Castiglia M, Van Der Steen N, Mertens I, Pauwels P, Peeters M, Rolfo C.
    J Vis Exp; 2016 May 27; (111):. PubMed ID: 27285610
    [Abstract] [Full Text] [Related]

  • 23. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
    Yuwen DL, Sheng BB, Liu J, Wenyu W, Shu YQ.
    Eur Rev Med Pharmacol Sci; 2017 Jun 27; 21(11):2650-2658. PubMed ID: 28678319
    [Abstract] [Full Text] [Related]

  • 24. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q, Fan T, Zhang B, Wang W, Xu Y, Hu H.
    Respir Res; 2014 Nov 25; 15(1):149. PubMed ID: 25421010
    [Abstract] [Full Text] [Related]

  • 25. Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC).
    Abdipourbozorgbaghi M, Vancura A, Radpour R, Haefliger S.
    Br J Cancer; 2024 Nov 25; 131(8):1350-1362. PubMed ID: 39215192
    [Abstract] [Full Text] [Related]

  • 26. Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia.
    Hanafi AR, Jayusman AM, Alfasunu S, Sadewa AH, Pramono D, Heriyanto DS, Haryana SM.
    Zhongguo Fei Ai Za Zhi; 2020 May 20; 23(5):321-332. PubMed ID: 32283582
    [Abstract] [Full Text] [Related]

  • 27. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F, Xuan Z, Yang X, Ye X, Pan Z, Fang Q.
    J Cell Biochem; 2020 Mar 20; 121(3):2690-2703. PubMed ID: 31692035
    [Abstract] [Full Text] [Related]

  • 28. microRNA-let-7e in serum-derived exosomes inhibits the metastasis of non-small-cell lung cancer in a SUV39H2/LSD1/CDH1-dependent manner.
    Xu S, Zheng L, Kang L, Xu H, Gao L.
    Cancer Gene Ther; 2021 Apr 20; 28(3-4):250-264. PubMed ID: 33299140
    [Abstract] [Full Text] [Related]

  • 29. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S, Sharawat SK, Ali A, Gaur V, Malik PS, Kumar S, Mohan A, Guleria R.
    Curr Probl Cancer; 2020 Aug 20; 44(4):100540. PubMed ID: 32007320
    [Abstract] [Full Text] [Related]

  • 30. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
    Zhang Y, Xu H.
    J Clin Lab Anal; 2020 Jun 20; 34(6):e23237. PubMed ID: 32061007
    [Abstract] [Full Text] [Related]

  • 31. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.
    Yang XR, Pi C, Yu R, Fan XJ, Peng XX, Zhang XC, Chen ZH, Wu X, Shao Y, Wu YL, Zhou Q.
    Clin Exp Metastasis; 2021 Feb 20; 38(1):109-117. PubMed ID: 33231826
    [Abstract] [Full Text] [Related]

  • 32. Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer.
    Wang N, Guo W, Song X, Liu L, Niu L, Song X, Xie L.
    Clin Chem Lab Med; 2020 Aug 27; 58(9):1535-1545. PubMed ID: 32271158
    [Abstract] [Full Text] [Related]

  • 33. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.
    Kim DH, Park S, Kim H, Choi YJ, Kim SY, Sung KJ, Sung YH, Choi CM, Yun M, Yi YS, Lee CW, Kim SY, Lee JC, Rho JK.
    Cancer Lett; 2020 Apr 10; 475():2-13. PubMed ID: 32004570
    [Abstract] [Full Text] [Related]

  • 34. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
    Hetta HF, Zahran AM, Shafik EA, El-Mahdy RI, Mohamed NA, Nabil EE, Esmaeel HM, Alkady OA, Elkady A, Mohareb DA, Hosni A, Mostafa MM, Elkady A.
    Microrna; 2019 Apr 10; 8(3):206-215. PubMed ID: 30652656
    [Abstract] [Full Text] [Related]

  • 35. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL, Chen Y, Sun Y, Yin YJ, Song CX.
    Clin Lab; 2017 Jan 01; 63(1):133-140. PubMed ID: 28164492
    [Abstract] [Full Text] [Related]

  • 36. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
    Kanaoka R, Iinuma H, Dejima H, Sakai T, Uehara H, Matsutani N, Kawamura M.
    Oncology; 2018 Jan 01; 94(5):311-323. PubMed ID: 29533963
    [Abstract] [Full Text] [Related]

  • 37. Cerebrospinal fluid exosomal microRNAs as biomarkers for diagnosing or monitoring the progression of non-small cell lung cancer with leptomeningeal metastases.
    Li H, Xia M, Zheng S, Lin Y, Yu T, Xie Y, Shen Y, Liu X, Qian X, Yin Z.
    Biotechnol Genet Eng Rev; 2024 Apr 01; 40(1):359-380. PubMed ID: 36852928
    [Abstract] [Full Text] [Related]

  • 38. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F, Shen Y, Chen Z, Li R, Lu J, Ge Q.
    Gene; 2016 Oct 15; 591(2):338-43. PubMed ID: 27291819
    [Abstract] [Full Text] [Related]

  • 39. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
    Pak MG, Lee CH, Lee WJ, Shin DH, Roh MS.
    Diagn Pathol; 2015 Jul 12; 10():99. PubMed ID: 26170125
    [Abstract] [Full Text] [Related]

  • 40. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
    Trakunram K, Chaniad P, Geater SL, Keeratichananont W, Chittithavorn V, Uttayamakul S, Buya S, Raungrut P, Thongsuksai P.
    Cancer Biol Med; 2020 Aug 15; 17(3):652-663. PubMed ID: 32944397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.